胸神经阻滞对乳腺癌术后疼痛及恢复质量的影响:随机对照试验
PECS阻滞改善术后6小时疼痛评分并降低维持BIS 40–50的丙泊酚目标血药浓度,但不减少瑞芬太尼用量,也未改善术后第1天QoR-40评分。
要点
- PECS阻滞改善术后6小时疼痛评分,但不改善术后第1天QoR-40评分。
- PECS阻滞降低丙泊酚维持BIS 40–50的目标血药浓度,但不减少瑞芬太尼用量。
- PECS阻滞不能到达内乳区,可能限制其对瑞芬太尼需求和恢复质量的改善。
核心结论
- 乳腺癌手术中PECS阻滞联合全麻减少丙泊酚需求但不减少瑞芬太尼需求,因PECS阻滞无法到达内乳区。
- PECS阻滞改善术后疼痛但未改善术后QoR-40评分,因反弹痛等镇痛无法即时测量的因素。
研究设计与样本
- 患者随机接受全麻诱导后0.25%左布比卡因30 ml PECS阻滞或生理盐水假阻滞。
- 术前及术后1天填写40项QoR问卷(QoR-40)。
主要发现
- 术后6小时中位[四分位距]疼痛评分PECS组1[0至2] vs 对照组1[0.25至2.75],P=0.018。
- 维持BIS 40–50的丙泊酚平均(±SD)估计目标血药浓度PECS组2.65(±0.52) vs 对照组3.08(±0.41) μg ml,P<0.001。
- 瑞芬太尼消耗量PECS组10.5(±4.28) vs 对照组10.4(±4.68) μg kg h,P=0.95。
- 术后第1天QoR-40评分PECS组182[176至189] vs 对照组174.5[157.75至175],未改善。
临床怎么用
- 乳腺癌手术可考虑PECS阻滞以改善术后早期疼痛并减少丙泊酚用量。
- 不应期望PECS阻滞减少瑞芬太尼用量或改善术后第1天恢复质量。
局限性
- PECS阻滞无法到达内乳区,可能限制其对瑞芬太尼需求和恢复质量的改善。
- 反弹痛等镇痛无法即时测量的因素可能影响QoR-40评分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In recent years, thoracic wall nerve blocks, such as the pectoral nerve (PECS) block and the serratus plane block have become popular for peri-operative pain control in patients undergoing breast cancer surgery. The effect of PECS block on quality of recovery (QoR) after breast cancer surgery has not been evaluated. OBJECTIVES: To evaluate the ability of PECS block to decrease postoperative pain and anaesthesia and analgesia requirements and to improve postoperative QoR in patients undergoing breast cancer surgery. DESIGN: Randomised controlled study. SETTING: A tertiary hospital. PATIENTS: Sixty women undergoing breast cancer surgery between April 2014 and February 2015. INTERVENTIONS: The patients were randomised to receive a PECS block consisting of 30 ml of levobupivacaine 0.25% after induction of anaesthesia (PECS group) or a saline mock block (control group). The patients answered a 40-item QoR questionnaire (QoR-40) before and 1 day after breast cancer surgery. MAIN OUTCOME MEASURES: Numeric Rating Scale score for postoperative pain, requirement for intra-operative propofol and remifentanil, and QoR-40 score on postoperative day 1. RESULTS: PECS block combined with propofol-remifentanil anaesthesia significantly improved the median [interquartile range] pain score at 6 h postoperatively (PECS group 1 [0 to 2] vs. Control group 1 [0.25 to 2.75]; P = 0.018]. PECS block also reduced propofol mean (± SD) estimated target blood concentration to maintain bispectral index (BIS) between 40 and 50 (PECS group 2.65 (± 0.52) vs. Control group 3.08 (± 0.41) μg ml; P < 0.001) but not remifentanil consumption (PECS group 10.5 (± 4.28) vs. Control group 10.4 (± 4.68) μg kg h; P = 0.95). PECS block did not improve the QoR-40 score on postoperative day 1 (PECS group 182 [176 to 189] vs. Control group 174.5 [157.75 to 175]). CONCLUSION: In patients undergoing breast cancer surgery, PECS block combined with general anaesthesia reduced the requirement for propofol but not that for remifentanil, due to the inability of the PECS block to reach the internal mammary area. Further, PECS block improved postoperative pain but not the postoperative QoR-40 score due to the factors that cannot be measured by analgesia immediately after surgery, such as rebound pain. TRIAL REGISTRATION: This trial is registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000013435).
引用
- Kamiya Y, Hasegawa M, Yoshida T, et al. Impact of pectoral nerve block on postoperative pain and quality of recovery in patients undergoing breast cancer surgery: A randomised controlled trial. Eur J Anaesthesiol. 2018. PMID: 29227351. doi:10.1097/EJA.0000000000000762
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。